HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elisidepsin Interacts Directly with Glycosylceramides in the Plasma Membrane of Tumor Cells to Induce Necrotic Cell Death.

Abstract
Plasma membrane integrity is essential for cell life. Any major break on it immediately induces the death of the affected cell. Different molecules were described as disrupting this cell structure and thus showing antitumor activity. We have previously defined that elisidepsin (Irvalec®, PM02734) inserts and self-organizes in the plasma membrane of tumor cells, inducing a rapid loss of membrane integrity, cell permeabilization and necrotic death. Here we show that, in sensitive HCT-116 colorectal cells, all these effects are consequence of the interaction of elisidepsin with glycosylceramides in the cell membrane. Of note, an elisidepsin-resistant subline (HCT-116-Irv) presented reduced levels of glycosylceramides and no accumulation of elisidepsin in the plasma membrane. Consequently, drug treatment did not induce the characteristic necrotic cell death. Furthermore, GM95, a mutant derivative from B16 mouse melanoma cells lacking ceramide glucosyltransferase (UGCG) activity and thus the synthesis of glycosylceramides, was also resistant to elisidepsin. Over-expression of UGCG gene in these deficient cells restored glycosylceramides synthesis, rendering them sensitive to elisidepsin, at a similar level than parental B16 cells. These results indicate that glycosylceramides act as membrane targets of elisidepsin, facilitating its insertion in the plasma membrane and the subsequent membrane permeabilization that leads to drug-induced cell death. They also indicate that cell membrane lipids are a plausible target for antineoplastic therapy.
AuthorsJosé Manuel Molina-Guijarro, Carolina García, Álvaro Macías, Luis Francisco García-Fernández, Cristina Moreno, Fernando Reyes, Juan Fernando Martínez-Leal, Rogelio Fernández, Valentín Martínez, Carmen Valenzuela, M Pilar Lillo, Carlos M Galmarini
JournalPloS one (PLoS One) Vol. 10 Issue 10 Pg. e0140782 ( 2015) ISSN: 1932-6203 [Electronic] United States
PMID26474061 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Depsipeptides
  • Glucosylceramides
  • elisidepsin
Topics
  • Animals
  • Cell Line, Tumor
  • Cell Membrane (metabolism, pathology)
  • Colorectal Neoplasms (drug therapy, genetics, metabolism, pathology)
  • Depsipeptides (pharmacology)
  • Glucosylceramides (genetics, metabolism)
  • Humans
  • Melanoma (drug therapy, genetics, metabolism, pathology)
  • Mice
  • Necrosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: